Korea Institute of Science and Technology

Lg Electronics Inc.

Agency for Defense Development

Jungryun Lee

Sukchan Lee

Kyoobin Lee

Jiyoung Jung

Yeon-Soo Kim

Chanki Kim

Daesoo Kim

Eunji Cheong

Hee-sup Shin

Bongsoo Roh

Hee-Sup Shin

Hyungseok Choi

Youngjae Kim

Hyoseok Lee

Okchun Hyun

Mijeong Hoh

Seungjae Baeck

Chanyi Park

Yihong Zheng

Seongwook Kim

Hyunho Choi

Maryam Sanati

Sukyung Lee

Eutteum Kong

Soonwook Choi

Myounghun Han

Uiseong Yu

The present invention relates to a dust collecting filter. The dust collecting filter of the present invention may include a ground electrode unit bent in a corrugated shape to form a plurality of bent portions and a plurality of flat portions between each of the plurality of bent portions, and grounded; and a plurality of voltage electrode units disposed between each of the plurality of flat portions and spaced apart from each other, and to which a high voltage is applied.

Dust collecting filter

Provided is a Weighted DESYNC based cross-layered resource allocation method. The method includes, with respect to each of a plurality of nodes constituting a routing path, calculating a link quality value with the next node, receiving a link quality value from at least one neighbor node, and based on the link quality values in the calculating of the link quality value and the receiving of the link quality value, calculating a weight factor for synchronizing a transmission yield.

Cross-layered resource allocation method based on weighted desync in wireless ad-hoc network

The present invention relates to a composition comprising PKC agonist as an active ingredient. More precisely, the present inventors confirmed that absence seizure specific SWD was reduced by administrating PKC agonist into an animal model. Therefore, the composition of the present invention comprising PKC agonist as an active ingredient can be effectively used for the prevention and treatment of absence seizure and for the production of health improving functional food.

Composition for the prevention and treatment of absence seizures comprising PKC agonist as an effective ingredient

The present invention relates to a novel use of an &#x3b1;1G T-type calcium channel transgenic mouse as a nervous disease model, more particularly, a novel use of a mouse deficient in &#x3b1;1G T-type calcium channel showing novelty-seeking and alcohol preference as a nervous disease model for human nervous related diseases such as novelty-seeking character, alcoholism, anxiety and emotion disorder by stress, etc. The &#x3b1;1G T-type channel transgenic mice showing novelty-seeking and alcohol preference of the present invention can be effectively used for the development of a medicine and a therapeutic method for human nervous diseases.

Mice lacking alpha 1G showing enhanced novelty-seeking and alcohol preference and therapeutic methods for mood disorders by modulating alpha 1G T-type calcium channels

Growing community of inventors

Seoul, South Korea

Jungryun Lee